GlassScriptPhysician profile
Ignazio D Perna
NPI 1730272915
$2,918.07
in general payments reported to CMS, 2019-2025
13 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $611 · 2020: $18.83 · 2021: $54.22 · 2022: $1,410 · 2023: $367 · 2024: $250 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $824.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $1,200.00 | 2022 | |
| Smith+Nephew, INC. | $633.05 | 2019-2025 | Pico 7, Grafix Pl |
| Organogenesis INC. | $406.17 | 2019-2025 | Puraply Wound Matrix, Puraply, Apligraf |
| Integra Lifesciences Corporation | $175.82 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $129.89 | 2019-2023 | Actishield |
| Boston Scientific Corporation | $111.78 | 2023-2024 | |
| Osteomed LLC | $109.39 | 2019-2022 | |
| Lilly USA, LLC | $60.49 | 2023-2024 | Mounjaro, Trulicity, Zepbound |
| Treace Medical Concepts, INC. | $32.56 | 2025 | |
| Paratek Pharmaceuticals, INC. | $16.54 | 2024 | Nuzyra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.24 | 2021 | |
| Abbvie INC. | $14.49 | 2023 | |
| Convatec INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ignazio Perna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.